enVVeno Medical Corp Operating Income
enVVeno Medical Corp (NVNO) reported Operating Income of -$3.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- enVVeno Medical Corp operating income (loss) for the quarter ending 2026-06-30 was -$3.80M.
- enVVeno Medical Corp operating income (loss) for the quarter ending 2026-03-31 was -$4.06M.
- enVVeno Medical Corp operating income (loss) for the quarter ending 2025-12-31 was -$4.01M.
- enVVeno Medical Corp operating income (loss) for the quarter ending 2025-09-30 was -$4.88M.
- enVVeno Medical Corp operating income (loss) for fiscal 2025 was -$20.90M.
- enVVeno Medical Corp operating income (loss) for fiscal 2024 was -$23.83M.
- enVVeno Medical Corp operating income (loss) for fiscal 2023 was -$25.24M.
- enVVeno Medical Corp operating income (loss) for fiscal 2022 was -$24.93M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.80M 10-Q · filed 2026-07-30 | -$7.86M 10-Q · filed 2026-07-30 | -$11.87M derived: sum of 3 quarters · filed 2026-07-30 | -$16.75M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$4.06M 10-Q · filed 2026-05-06 | -$8.07M derived: sum of 2 quarters · filed 2026-05-06 | -$12.96M derived: sum of 3 quarters · filed 2026-05-06 | -$20.01M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$8.90M derived: sum of 2 quarters · filed 2026-03-26 | -$15.95M derived: sum of 3 quarters · filed 2026-07-30 | -$20.90M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$4.88M 10-Q · filed 2025-10-30 | -$11.93M derived: sum of 2 quarters · filed 2026-07-30 | -$16.89M 10-Q · filed 2025-10-30 | -$23.59M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$7.05M 10-Q · filed 2026-07-30 | -$12.00M 10-Q · filed 2026-07-30 | -$18.70M derived: sum of 3 quarters · filed 2026-07-30 | -$24.87M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$4.95M 10-Q · filed 2026-05-06 | -$11.65M derived: sum of 2 quarters · filed 2026-05-06 | -$17.82M derived: sum of 3 quarters · filed 2026-05-06 | -$23.28M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$12.87M derived: sum of 2 quarters · filed 2026-03-26 | -$18.32M derived: sum of 3 quarters · filed 2026-03-26 | -$23.83M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$6.17M 10-Q · filed 2025-10-30 | -$11.62M derived: sum of 2 quarters · filed 2025-10-30 | -$17.13M 10-Q · filed 2025-10-30 | -$23.41M derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | -$5.45M 10-Q · filed 2025-07-31 | -$10.96M 10-Q · filed 2025-07-31 | -$17.23M derived: sum of 3 quarters · filed 2025-07-31 | -$22.58M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | -$5.50M 10-Q · filed 2025-04-30 | -$11.78M derived: sum of 2 quarters · filed 2025-04-30 | -$17.13M derived: sum of 3 quarters · filed 2025-04-30 | -$23.94M derived: sum of 4 quarters · filed 2025-04-30 | ||||
| 2023-12-31 | -$6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$11.63M derived: sum of 2 quarters · filed 2025-02-28 | -$18.44M derived: sum of 3 quarters · filed 2025-02-28 | -$25.24M 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | -$5.35M 10-Q · filed 2024-10-31 | -$12.16M derived: sum of 2 quarters · filed 2024-10-31 | -$18.96M 10-Q · filed 2024-10-31 | -$25.42M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | -$6.81M 10-Q · filed 2024-07-31 | -$13.61M 10-Q · filed 2024-07-31 | -$20.07M derived: sum of 3 quarters · filed 2024-07-31 | -$26.22M derived: sum of 4 quarters · filed 2024-07-31 | ||||
| 2023-03-31 | -$6.80M 10-Q · filed 2024-05-08 | -$13.26M derived: sum of 2 quarters · filed 2024-05-08 | -$19.41M derived: sum of 3 quarters · filed 2024-05-08 | -$26.39M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$6.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$12.61M derived: sum of 2 quarters · filed 2024-02-29 | -$19.60M derived: sum of 3 quarters · filed 2024-02-29 | -$24.93M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$6.15M 10-Q · filed 2023-10-26 | -$13.14M derived: sum of 2 quarters · filed 2023-10-26 | -$18.47M 10-Q · filed 2023-10-26 | -$27.46M derived: sum of 4 quarters · filed 2023-10-26 | ||||
| 2022-06-30 | -$6.99M 10-Q · filed 2023-07-31 | -$12.32M 10-Q · filed 2023-07-31 | -$21.31M derived: sum of 3 quarters · filed 2023-07-31 | -$24.02M derived: sum of 4 quarters · filed 2023-07-31 | ||||
| 2022-03-31 | -$5.33M 10-Q · filed 2023-04-28 | -$14.33M derived: sum of 2 quarters · filed 2023-04-28 | -$17.04M derived: sum of 3 quarters · filed 2023-04-28 | -$19.42M derived: sum of 4 quarters · filed 2023-04-28 | ||||
| 2021-12-31 | -$8.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$11.70M derived: sum of 2 quarters · filed 2023-03-02 | -$14.09M derived: sum of 3 quarters · filed 2023-03-02 | -$16.89M 10-K · filed 2023-03-02 | -$16.89M 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$2.71M 10-Q · filed 2022-10-27 | -$2.71M 10-Q · filed 2021-11-12 | -$5.09M derived: sum of 2 quarters · filed 2022-10-27 | -$7.90M 10-Q · filed 2022-10-27 | -$7.90M 10-Q · filed 2021-11-12 | -$12.06M derived: sum of 4 quarters · filed 2022-10-27 | ||
| 2021-06-30 | -$2.39M 10-Q · filed 2022-08-03 | -$2.39M 10-Q · filed 2021-08-11 | -$5.19M 10-Q · filed 2022-08-03 | -$5.19M 10-Q · filed 2021-08-11 | -$9.35M derived: sum of 3 quarters · filed 2022-08-03 | -$11.27M derived: sum of 4 quarters · filed 2022-08-03 | ||
| 2021-03-31 | -$2.81M 10-Q · filed 2022-04-29 | -$2.81M 10-Q · filed 2021-05-12 | -$6.97M derived: sum of 2 quarters · filed 2022-04-29 | -$8.89M derived: sum of 3 quarters · filed 2022-04-29 | -$10.43M derived: sum of 4 quarters · filed 2022-04-29 | |||
| 2020-12-31 | -$4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$6.08M derived: sum of 2 quarters · filed 2022-03-28 | -$7.63M derived: sum of 3 quarters · filed 2022-03-28 | -$9.14M 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | -$1.92M 10-Q · filed 2021-11-12 | -$3.47M derived: sum of 2 quarters · filed 2021-11-12 | -$4.98M 10-Q · filed 2021-11-12 | -$7.28M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$1.55M 10-Q · filed 2021-08-11 | -$3.05M 10-Q · filed 2021-08-11 | -$5.35M derived: sum of 3 quarters · filed 2021-08-11 | -$7.19M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$1.51M 10-Q · filed 2021-05-12 | -$3.81M derived: sum of 2 quarters · filed 2021-05-12 | -$5.64M derived: sum of 3 quarters · filed 2021-05-12 | -$7.60M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$4.13M derived: sum of 2 quarters · filed 2021-03-31 | -$6.09M derived: sum of 3 quarters · filed 2021-03-31 | -$7.68M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$1.83M 10-Q · filed 2020-11-17 | -$3.79M derived: sum of 2 quarters · filed 2020-11-17 | -$5.38M 10-Q · filed 2020-11-17 | -$7.18M derived: sum of 4 quarters · filed 2020-11-17 | ||||
| 2019-06-30 | -$1.96M 10-Q · filed 2020-08-14 | -$1.96M 10-Q · filed 2019-08-05 | -$3.54M 10-Q · filed 2020-08-14 | -$5.34M derived: sum of 3 quarters · filed 2020-08-14 | -$6.83M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$1.58M 10-Q · filed 2020-06-08 | -$3.38M derived: sum of 2 quarters · filed 2020-06-08 | -$4.87M derived: sum of 3 quarters · filed 2020-06-08 | -$7.98M derived: sum of 4 quarters · filed 2020-06-08 | ||||
| 2018-12-31 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | -$3.29M derived: sum of 2 quarters · filed 2020-03-18 | -$6.40M derived: sum of 3 quarters · filed 2020-03-18 | -$7.85M 10-K · filed 2020-03-18 | ||||
| 2018-09-30 | -$1.49M 10-Q · filed 2019-10-31 | -$4.60M derived: sum of 2 quarters · filed 2019-10-31 | -$6.06M 10-Q · filed 2019-10-31 | -$7.98M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | -$3.11M 10-Q · filed 2019-08-05 | -$4.57M 10-Q · filed 2019-08-05 | -$6.50M derived: sum of 3 quarters · filed 2019-08-05 | -$8.31M derived: sum of 4 quarters · filed 2019-08-05 | ||||
| 2018-03-31 | -$1.46M 10-Q · filed 2019-05-09 | -$3.39M derived: sum of 2 quarters · filed 2019-05-09 | -$5.20M derived: sum of 3 quarters · filed 2019-05-09 | -$6.43M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$3.74M derived: sum of 2 quarters · filed 2019-03-14 | -$4.97M derived: sum of 3 quarters · filed 2019-03-14 | -$6.10M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | -$1.81M 10-Q · filed 2018-11-07 | -$3.04M derived: sum of 2 quarters · filed 2018-11-07 | -$4.17M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$1.23M 10-Q · filed 2018-08-10 | -$2.36M 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |